SAN FRANCISCO, Sept. 27, 2019 /PRNewswire/ -- EchoPixel is introducing the first-ever intraoperative software to provide naked-eye, touchless interactive 3D anatomical imaging to support structural heart procedures in the cath lab, OR and hybrid OR's, here, at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 meeting, September 25-29, 2019 (Booth #952). The company will showcase the turnkey intraoperative solution* as part of its existing integrated suite of mixed reality software solutions that assist cardiologists and surgeons with visualization of live 3D medical images during a procedure for more precise catheter and device placement and personalized planning.
"Building on the success of our existing technology in pediatric congenital heart procedures, EchoPixel is committed to enabling digital surgery by providing and continuously improving transformative technology designed to help clinicians improve and personalize delivery of minimally invasive therapies. Going forward, our vision for the OR of the Future involves expanding our mixed reality True3D software platform to integrate Artificial Intelligence (AI) and robotics to enable the completion of more precise and personalized procedures," said Sergio Aguirre, CEO, EchoPixel.
The innovative anatomical imaging tools provide clinicians with a 3D holographic experience to visualize and interact with patient-specific organs and tissue in an open 3D space. This allows for enhanced pre-operative planning, improved patient selection, increased patient engagement and the completion of increasingly complex structural heart and congenital heart disease procedures in both adults and pediatric patients.
Ad Statistics
Times Displayed: 17835
Times Visited: 333 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
"EchoPixel's technology lets you effortlessly interact with 3D images to better understand complex cardiac anatomy and the anatomic variability that is commonly seen in structural heart disease patients. We are currently working on a research study comparing procedure times with and without the technology, and the initial results are promising in terms of reducing procedure times and device waste. If these results continue, I think the technology will make structural heart procedures more efficient and more accessible to patients," said Saurabh Sanon, MD, director of the Structural Heart Transcatheter Therapies program at Palm Beach Gardens Medical Center and clinical associate professor of medicine at Florida Atlantic University's College of Medicine.
